Shares of ValiRx plc (LON:VAL – Get Free Report) were down 12.8% on Monday . The stock traded as low as GBX 0.53 ($0.01) and last traded at GBX 0.57 ($0.01). Approximately 9,117,890 shares were traded during mid-day trading, a decline of 22% from the average daily volume of 11,719,508 shares. The stock had previously closed at GBX 0.65 ($0.01).
ValiRx Stock Performance
The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.27 and a current ratio of 6.65. The company has a market capitalization of £2.07 million, a P/E ratio of -0.37 and a beta of 0.59. The firm has a 50 day moving average price of GBX 0.73 and a two-hundred day moving average price of GBX 1.39.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Financial Services Stocks Investing
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- The How And Why of Investing in Oil Stocks
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
